MetaCap

Dr. Reddy's Laboratories Ltd (RDY)

NYSE: RDYHealth CareBiotechnology: Pharmaceutical PreparationsUSD

14.89+0.06 (+0.40%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

RDY stock chart

Technical analysis

Key statistics

All statistics
Market cap
$12.41B
Dividend yield
53.73% ($8.00)
Ex-dividend date
Jul 24, 2026
52-week range
11.36 – 15.67
Day range
14.86 – 15.10
Volume / Avg
1.74M / 2.85M
Beta
—

52-week range

$11.36$15.67

RDY stock today

On Nov 20, RDY ended the session at $14.89, adding $0.06 (0.40%), versus the S&P 500's 3.70% decline. Shares are 5.0% below their 52-week high of $15.67, set on Jun 26, 2026 and 31.1% above the 52-week low of $11.36, near the top of the past year's range. RDY is up 6.1% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 7.0%.

Dr. Reddy's Laboratories trades at 41.4x its trailing twelve-month earnings per share of $0.36. Its forward P/E of 22.5x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Dr. Reddy's Laboratories pays an annual dividend of $8.00 per share, a 53.73% yield at the current price.

Summary generated from market data by MetaCap's automated system. Methodology

About Dr. Reddy's Laboratories

Company profile

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. The company operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment.

Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Erez Israeli M.B.A.
Headquarters
Hyderabad
Employees
27,527

Financial highlights

Full financials

In fiscal 2025, Dr. Reddy's Laboratories generated $3.81 billion in revenue, up 13.8% from fiscal 2024, its 7th consecutive year of revenue growth. Net income was $663.0 million (-0.7% year over year), for a net margin of 17.4% versus a median of 11.2% in the prior 5 years. Gross margin was 58.5% (down from 58.6%) and operating margin 22.1%.

Dr. Reddy's Laboratories annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$3.81B$3.35B$2.99B$2.83B$2.59B
Growth+13.76%+11.97%+5.87%+8.94%+12.00%
Net income$663.00M$668.00M$548.00M$311.00M$236.00M
EPS (diluted)$0.79$4.01$3.30$1.87$1.52

Analyst forecast

Forecast

Consensus (5 analysts)

buy

Avg. price target

$14.92+0.20%

  • Strong buy 1
  • Buy 2
  • Hold 1
  • Sell 0
  • Strong sell 1

Target range

Low $12.75High $16.26

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Oct 23, 2026
EPS actual vs est.
$0.19 vs $0.16
Surprise
+18.75%

Dividends

Dividend history
Annual dividend
$8.00
Last payment
$0.083
Ex-dividend date
Jul 24, 2026

RDY news

All RDY news

Dr. Reddy's Laboratories peers

Health Care sector
RDY peer companies
CompanyPrice% ChgMarket capCompare
ELANElanco Animal Health Incorporated25.74-2.09%$12.87Bvs RDY
BMRNBioMarin Pharmaceutical Inc.60.41-1.64%$11.70Bvs RDY
JAZZJazz Pharmaceuticals plc230.26-2.62%$14.78Bvs RDY
BBIOBridgeBio Pharma Inc.76.03-2.75%$14.81Bvs RDY
TGTXTG Therapeutics Inc.63.34-2.37%$9.57Bvs RDY
SYRESpyre Therapeutics Inc.93.47-4.26%$8.88Bvs RDY
MDGLMadrigal Pharmaceuticals Inc.379.10-4.45%$8.81Bvs RDY
PRAXPraxis Precision Medicines Inc.300.43-3.37%$8.40Bvs RDY

Indexes, lists and sector

Dr. Reddy's Laboratories stock FAQ

What is Dr. Reddy's Laboratories's stock price today?

RDY last traded at $14.89 as of Nov 20, 4:00 PM EST, up 0.40% on the day. Prices are delayed at least 15 minutes.

Does Dr. Reddy's Laboratories pay a dividend?

Yes. Dr. Reddy's Laboratories pays $8.00 per share annually, a 53.73% yield. The most recent dividend of $0.083 had an ex-dividend date of Jul 24, 2026.

What is RDY's P/E ratio?

RDY trades at a trailing P/E ratio of 41.36 and a forward P/E of 22.47.

Who is Dr. Reddy's Laboratories's CEO?

Mr. Erez Israeli M.B.A. is the chief executive officer of Dr. Reddy's Laboratories Ltd, which has about 27,527 employees.

Has RDY ever split its stock?

Yes. The most recent RDY stock split was a 5-for-1 split on Nov 5, 2024, one of 2 splits on record.

What is the RDY 52-week high?

The 52-week high for RDY is $15.67 and the 52-week low is $11.36. The stock is currently 5.0% below its high.

Compare RDY